Polyrizon Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, dated November 25, 2025, reports a corporate action by Polyrizon Ltd., a foreign private issuer headquartered in Raanana, Israel. The filing announces the implementation of a reverse share split for the Company's ordinary shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on capital structure adjustments.
Material Changes
- Reverse Share Split: The Company is effecting a 1-for-6 reverse share split.
- Share Count Adjustment: Issued and outstanding ordinary shares will decrease from 6,250,053 to 1,041,676 (subject to fractional share adjustments).
- Trading Resumption: Trading on the Nasdaq Capital Market under the new structure will commence on Friday, November 28, 2025.
- Fractional Shares: No fractional shares will be issued; amounts greater than 0.5 will be rounded to the nearest whole share.
- Derivatives Adjustment: A proportionate adjustment will be made to the exercise price and share count for all outstanding warrants and options.
- Authorized Capital: The authorized share capital remains unchanged.
- New CUSIP: The new CUSIP number for the ordinary shares is M79549206.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding financial guidance, future outlook, specific risks, or contingencies beyond the mechanics of the share split. No unusual items were reported.
Investor Verification Checklist
- Verify the exact number of shares held post-split, accounting for the rounding of fractional shares.
- Confirm the updated exercise price and share count for any held options or warrants.
- Ensure trading systems are updated to reflect the new CUSIP (M79549206) effective November 28, 2025.
- Review the Company's Form 20-F for the most recent audited financial statements, as this filing does not contain financial performance data.